Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BPGM | P07738 | 6/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GPR52 | Q9Y2T5 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | ROCK2 | O75116 | 5/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.33 |
| ▸ | PRKACA | P17612 | 1/20 | 0.33 |
| ▸ | PRKACG | P22612 | 1/20 | 0.33 |
| ▸ | PRKACB | P22694 | 1/20 | 0.33 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24348053 | 0.84 | BPGM (0.36) | BPGMGPR52PDPK1ADORA2A | |
| SCHEMBL24349005 | 0.83 | BPGM (0.56) | BPGMMAPTNPC1RAB9AROCK2 | |
| SCHEMBL24349254 | 0.83 | BPGM (0.42) | BPGMMAPTROCK2ROCK1PRKACA | |
| SCHEMBL24349278 | 0.82 | BPGM (0.44) | BPGMMAPTGPR52RAB9AROCK2 | |
| SCHEMBL24349240 | 0.80 | BPGM (0.47) | BPGMMAPTGPR52RAB9A | |
| SCHEMBL24348976 | 0.80 | BPGM (0.52) | BPGMMAPTGPR52ROCK2ROCK1 | |
| SCHEMBL26704310 | 0.80 | BPGM (0.46) | BPGMMAPTGPR52ROCK2ROCK1 | |
| SCHEMBL24349408 | 0.79 | BPGM (0.64) | BPGMMAPTROCK2ROCK1PRKACA | |
| SCHEMBL24348921 | 0.79 | BPGM (0.64) | BPGMMAPTGPR52ROCK2ROCK1 | |
| SCHEMBL24348060 | 0.79 | BPGM (0.54) | BPGMMAPTROCK2ROCK1PRKACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022056449-A1 | COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE | GENZYME CORPORATION (US) | 2022-03-17 | — | — | WO | disclosed |